Nvidia’s Rough Week… And Why Users Start & Stop GLP-1 Drugs 1/31/25

Nvidia wrapping up a rough week, as the chip giant enters bear market territory. The concerns surrounding China’s DeepSeek AI model, and if the chip crunch has our traders rethinking tech’s leadership. Plus.. weight loss drugs taking the market by storm, and a new study is diving deeper into why consumers are starting and stopping usage. The factors contributing to their decision, and what it means for the entire obesity drug space. Fast Money Disclaimer